Amgen

Open: 236.48 Close: 234.15 Change: -2.33

What an AI found about Amgen after reading the whole Internet.

The game is changing. There is a new strategy to evaluate Amgen fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, Amgens, August, NASDAQAMGN, stock, patient, earnings, and the …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen (NASDAQ:AMGN) stock price for Amgen is $ 234.15 last updated Today at July 31, 2023 at 8:00 PM UTC. Amgen and TSCAN THERAPEUTics have announced a deal for Horizon Therapeutics.

Today's News

The states of California, Minnesota and Wisconsin join a Federal Trade Commission lawsuit to stop Amgens $27.8 billion deal. U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents. FTC faces uphill battle in its fight against $27.8 billion takeover of Horizon Therapeutics. Amgen CEO Bob Bradway recently spoke to Amgens summer intern class. #ImpactSquared: How will the development of prescription medicines and ground-breaking science be affected by policies like the Inflation Reduction Act? AbbVies Skyrizi was deemed more effective when compared to Amgens Otezla among adult patients with moderate plaque psoriasis eligible for systemic therapy. Amgen will be looking to display strength as it nears its next earnings release, which is expected to be August 3, 2023. By clicking the I agree button, I am electronically indicating that I have read and understood Amgens Patient Authorization (above in its full text) I am providing my consent as the patient or the patients legal representative for Amgen and its contractors and business partners to use and share the personal information I provide for the purposes described within the Patient Authorization. This program helps eligible patients cover out-of-pocket medication costs related to an Amgen SupportPlus product, up to program limits. This offer is not valid for patients whose prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state. Amgen SupportPlus Co-Pay Card benefits to reduce a patients out-of-pocket costs. Patients may use the card every time they receive a prescription fill, dose or cycle of the Amgen supportPlus product. Amgen has 1708 competitors, of which 1512 are active, 245 are funded and 441 have exited. Pfizer - New York City based , 1849 founded , Public company. Amgen and TSCAN THERAPEUTics announce collaboration to IDENTIFY NOVEL TARGETS in CROHNS disease. Amgen Stock (NASDAQ:AMGN), Quotes and News Summary Amgen stock price, news, charts, charts and stock research, profile. Amgen (NASDAQ:AMGN) is in the Health Care sector and Biotechnology industry. Amgens Q2 earnings are confirmed for Thursday, August 3, 2023. Amgen, FTC said there are no ongoing talks to settle over Horizon Therapeutics deal. Amgen and TSCAN THERAPEUTics announced collaboration to IDENTIFy Novel TARGETS in CROHNS disease. Amgen and TSCAN THERAPEUTics have announced a deal for Horizon Therapeutics. Amgen (NASDAQ:AMGN) is in the Health Care sector and Biotechnology industry. The stock price for Amgen is $ 234.15 last updated Today at July 31, 2023 at 8:00 PM UTC. Amgens Q2 earnings are confirmed for Thursday, August 3. Amgen, FTC said there are no ongoing talks to settle over Horizon Therapeutics deal. Amgen is in the Health Care sector and Biotechnology industry. Q2 earnings are confirmed for August 3, 2023. Amgen and TSCAN THERAPEUTics announced collaboration to identify novel targets in CROHNS disease. Amgen (NASDAQ:AMGN) stock price for Amgen is $ 234.15 last updated Today at July 31, 2023 at 8:00 PM UTC. Amgens Q2 earnings are confirmed for Thursday, August 3, 20 23. Q2 Earnings are scheduled for August 3. Amgen (NASDAQ:AMGN) stock price is $ 234.15 last updated Today at July 31, 2023 at 8:00 PM UTC. Amgen is in the Health Care sector and Biotechnology industry. The latest price target for Amgen was reported by Oppenheimer on Tuesday, July 25, 20th. Amgen and TSCAN THERAPEUTics announce collaboration to IDENTIFY NOVEL TARGETS in CROHNS DISEASE. Amgen Stock (NASDAQ:AMGN), Quotes and News Summary Amgen stock price, news, charts, charts and stock research, profile. Amgen (NASDAQ:AMGN) is in the Health Care sector and Biotechnology industry. Q2 earnings are confirmed for Thursday, August 3, 2023. There is no upcoming split for Amgen. IFPA, with support from Amgen, issued a call for actionable solutions to unite people living with psoriatic disease and their healthcare providers. GHLF received a grant for BIPOC Patient Voices: Living with Psoriasis.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

This document will help you to evaluate Amgen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, Amgens, August, NASDAQAMGN, stock, patient, earnings, and the most common words in the summary are: amgen, coverage, late, read, stock, job, best, . One of the sentences in the summary was: Amgen and TSCAN THERAPEUTics have announced a deal for Horizon Therapeutics.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #coverage #late #read #stock #job #best.